Evidence map›Paper›PMID 33681157›Full record

ReviewFrontiers in bioengineering and biotechnology2021

Bioactive Materials for Soft Tissue Repair.

Elisa Mazzoni, Maria Rosa Iaquinta, Carmen Lanzillotti, Chiara Mazziotta, Martina Maritati, Monica Montesi, Simone Sprio, Anna Tampieri, Mauro Tognon, Fernanda Martini

Abstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Incorporation of Poly(propylene succinate-ACS applied bio materials · 2025
    Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Elisa MazzoniDepartment of Medical Sciences, University of Ferrara, Ferrara, Italy.
Maria Rosa IaquintaDepartment of Medical Sciences, University of Ferrara, Ferrara, Italy.
Carmen LanzillottiDepartment of Medical Sciences, University of Ferrara, Ferrara, Italy.
Chiara MazziottaDepartment of Medical Sciences, University of Ferrara, Ferrara, Italy.
Martina MaritatiDepartment of Medical Sciences, University of Ferrara, Ferrara, Italy.
Monica MontesiInstitute of Science and Technology for Ceramics-National Research Council (ISTEC-CNR), Faenza, Italy.
Simone SprioInstitute of Science and Technology for Ceramics-National Research Council (ISTEC-CNR), Faenza, Italy.
Anna TampieriInstitute of Science and Technology for Ceramics-National Research Council (ISTEC-CNR), Faenza, Italy.
Mauro TognonDepartment of Medical Sciences, University of Ferrara, Ferrara, Italy.
Fernanda MartiniDepartment of Medical Sciences, University of Ferrara, Ferrara, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past decades, age-related pathologies have increased abreast the aging population worldwide. The increased age of the population indicates that new tools, such as biomaterials/scaffolds for damaged tissues, which display high efficiency, effectively and in a limited period of time, for the regeneration of the body's tissue are needed. Indeed, scaffolds can be used as templates for three-dimensional tissue growth in order to promote the tissue healing stimulating the body's own regenerative mechanisms. In tissue engineering, several types of biomaterials are employed, such as bioceramics including calcium phosphates, bioactive glasses, and glass-ceramics. These scaffolds seem to have a high potential as biomaterials in regenerative medicine. In addition, in conjunction with other materials, such as polymers, ceramic scaffolds may be used to manufacture composite scaffolds characterized by high biocompatibility, mechanical efficiency and load-bearing capabilities that render these biomaterials suitable for regenerative medicine applications. Usually, bioceramics have been used to repair hard tissues, such as bone and dental defects. More recently, in the field of soft tissue engineering, this form of scaffold has also shown promising applications. Indeed, soft tissues are continuously exposed to damages, such as burns or mechanical traumas, tumors and degenerative pathology, and, thereby, thousands of people need remedial interventions such as biomaterials-based therapies. It is known that scaffolds can affect the ability to bind, proliferate and differentiate cells similar to those of autologous tissues. Therefore, it is important to investigate the interaction between bioceramics and somatic/stem cells derived from soft tissues in order to promote tissue healing. Biomimetic scaffolds are frequently employed as drug-delivery system using several therapeutic molecules to increase their biological performance, leading to ultimate products with innovative functionalities. This review provides an overview of essential requirements for soft tissue engineering biomaterials. Data on recent progresses of porous bioceramics and composites for tissue repair are also presented.

Indexed as

bioceramicbioglassesbiomimeticdeliverysoft tissue

Identifiers

PMID33681157
PMCPMC7933465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.